Global Pharmaceutical Blockchain Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • receipt Report ID : 143380
  • calendar_today Published On: Feb, 2023
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The global Blockchain in Pharmaceutical market size is projected to reach US$ 30519 million by 2026, from US$ 1010.2 million in 2019, at a CAGR of 72.77% during 2021-2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blockchain in Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blockchain in Pharmaceutical market in terms of revenue.

According to our latest study, the global Pharmaceutical Blockchain market size was valued at USD 1794.5 million in 2022 and is forecast to a readjusted size of USD 2245.3 million by 2029 with a CAGR of 3.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91% in 2019.

For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69% in 2019.

This report is a detailed and comprehensive analysis for global Pharmaceutical Blockchain market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Pharmaceutical Blockchain market size and forecasts, in consumption value ($ Million), 2018-2029

Global Pharmaceutical Blockchain market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Pharmaceutical Blockchain market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Pharmaceutical Blockchain market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Pharmaceutical Blockchain

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Pharmaceutical Blockchain market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chronicled Inc., Doc.AI, Embleema, Factom Inc. and FarmaTrust, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Pharmaceutical Blockchain market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Public

Private

Market segment by Application

Supply Chian Management

Clinical Data Exchange and Interoperability

Drug Development

Clinical Trials

Internet of Medical Things (IOMT)& Cyber Security

Other Applications

Market segment by players, this report covers

Chronicled Inc.

Doc.AI

Embleema

Factom Inc.

FarmaTrust

Guardtime Federal

Hashed Health

IBM Corporation

Medicalchain

Microsoft Corporation

Organizations Mentioned

American Society of Clinical Oncology (ASCO)

Association of Clinical Trials Organizations (ACTO)

Castor EDC

Clinical Supplies Management Holdings, Inc.

ClinicalTrials.gov

Medpace

N-SIDE

Quanticate

Society for Clinical Trials

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Argentina and Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Pharmaceutical Blockchain product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Pharmaceutical Blockchain, with revenue, gross margin and global market share of Pharmaceutical Blockchain from 2018 to 2023.

Chapter 3, the Pharmaceutical Blockchain competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical Blockchain market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical Blockchain.

Chapter 13, to describe Pharmaceutical Blockchain research findings and conclusion.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Pharmaceutical Blockchain

1.2 Market Estimation Caveats and Base Year

1.3 Classification of Pharmaceutical Blockchain by Type

1.3.1 Overview: Global Pharmaceutical Blockchain Market Size by Type: 2018 Versus 2022 Versus 2029

1.3.2 Global Pharmaceutical Blockchain Consumption Value Market Share by Type in 2022

1.3.3 Public

1.3.4 Private

1.4 Global Pharmaceutical Blockchain Market by Application

1.4.1 Overview: Global Pharmaceutical Blockchain Market Size by Application: 2018 Versus 2022 Versus 2029

1.4.2 Supply Chian Management

1.4.3 Clinical Data Exchange and Interoperability

1.4.4 Drug Development

1.4.5 Clinical Trials

1.4.6 Internet of Medical Things (IOMT)& Cyber Security

1.4.7 Other Applications

1.5 Global Pharmaceutical Blockchain Market Size & Forecast

1.6 Global Pharmaceutical Blockchain Market Size and Forecast by Region

1.6.1 Global Pharmaceutical Blockchain Market Size by Region: 2018 VS 2022 VS 2029

1.6.2 Global Pharmaceutical Blockchain Market Size by Region, (2018-2029)

1.6.3 North America Pharmaceutical Blockchain Market Size and Prospect (2018-2029)

1.6.4 Europe Pharmaceutical Blockchain Market Size and Prospect (2018-2029)

1.6.5 Asia-Pacific Pharmaceutical Blockchain Market Size and Prospect (2018-2029)

1.6.6 South America Pharmaceutical Blockchain Market Size and Prospect (2018-2029)

1.6.7 Middle East and Africa Pharmaceutical Blockchain Market Size and Prospect (2018-2029)

2 Company Profiles

2.1 Chronicled Inc.

2.1.1 Chronicled Inc. Details

2.1.2 Chronicled Inc. Major Business

2.1.3 Chronicled Inc. Pharmaceutical Blockchain Product and Solutions

2.1.4 Chronicled Inc. Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 Chronicled Inc. Recent Developments and Future Plans

2.2 Doc.AI

2.2.1 Doc.AI Details

2.2.2 Doc.AI Major Business

2.2.3 Doc.AI Pharmaceutical Blockchain Product and Solutions

2.2.4 Doc.AI Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 Doc.AI Recent Developments and Future Plans

2.3 Embleema

2.3.1 Embleema Details

2.3.2 Embleema Major Business

2.3.3 Embleema Pharmaceutical Blockchain Product and Solutions

2.3.4 Embleema Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 Embleema Recent Developments and Future Plans

2.4 Factom Inc.

2.4.1 Factom Inc. Details

2.4.2 Factom Inc. Major Business

2.4.3 Factom Inc. Pharmaceutical Blockchain Product and Solutions

2.4.4 Factom Inc. Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 Factom Inc. Recent Developments and Future Plans

2.5 FarmaTrust

2.5.1 FarmaTrust Details

2.5.2 FarmaTrust Major Business

2.5.3 FarmaTrust Pharmaceutical Blockchain Product and Solutions

2.5.4 FarmaTrust Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 FarmaTrust Recent Developments and Future Plans

2.6 Guardtime Federal

2.6.1 Guardtime Federal Details

2.6.2 Guardtime Federal Major Business

2.6.3 Guardtime Federal Pharmaceutical Blockchain Product and Solutions

2.6.4 Guardtime Federal Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 Guardtime Federal Recent Developments and Future Plans

2.7 Hashed Health

2.7.1 Hashed Health Details

2.7.2 Hashed Health Major Business

2.7.3 Hashed Health Pharmaceutical Blockchain Product and Solutions

2.7.4 Hashed Health Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 Hashed Health Recent Developments and Future Plans

2.8 IBM Corporation

2.8.1 IBM Corporation Details

2.8.2 IBM Corporation Major Business

2.8.3 IBM Corporation Pharmaceutical Blockchain Product and Solutions

2.8.4 IBM Corporation Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.8.5 IBM Corporation Recent Developments and Future Plans

2.9 Medicalchain

2.9.1 Medicalchain Details

2.9.2 Medicalchain Major Business

2.9.3 Medicalchain Pharmaceutical Blockchain Product and Solutions

2.9.4 Medicalchain Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.9.5 Medicalchain Recent Developments and Future Plans

2.10 Microsoft Corporation

2.10.1 Microsoft Corporation Details

2.10.2 Microsoft Corporation Major Business

2.10.3 Microsoft Corporation Pharmaceutical Blockchain Product and Solutions

2.10.4 Microsoft Corporation Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.10.5 Microsoft Corporation Recent Developments and Future Plans

2.11 Organizations Mentioned

2.11.1 Organizations Mentioned Details

2.11.2 Organizations Mentioned Major Business

2.11.3 Organizations Mentioned Pharmaceutical Blockchain Product and Solutions

2.11.4 Organizations Mentioned Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.11.5 Organizations Mentioned Recent Developments and Future Plans

2.12 American Society of Clinical Oncology (ASCO)

2.12.1 American Society of Clinical Oncology (ASCO) Details

2.12.2 American Society of Clinical Oncology (ASCO) Major Business

2.12.3 American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Product and Solutions

2.12.4 American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.12.5 American Society of Clinical Oncology (ASCO) Recent Developments and Future Plans

2.13 Association of Clinical Trials Organizations (ACTO)

2.13.1 Association of Clinical Trials Organizations (ACTO) Details

2.13.2 Association of Clinical Trials Organizations (ACTO) Major Business

2.13.3 Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Product and Solutions

2.13.4 Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.13.5 Association of Clinical Trials Organizations (ACTO) Recent Developments and Future Plans

2.14 Castor EDC

2.14.1 Castor EDC Details

2.14.2 Castor EDC Major Business

2.14.3 Castor EDC Pharmaceutical Blockchain Product and Solutions

2.14.4 Castor EDC Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.14.5 Castor EDC Recent Developments and Future Plans

2.15 Clinical Supplies Management Holdings, Inc.

2.15.1 Clinical Supplies Management Holdings, Inc. Details

2.15.2 Clinical Supplies Management Holdings, Inc. Major Business

2.15.3 Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Product and Solutions

2.15.4 Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.15.5 Clinical Supplies Management Holdings, Inc. Recent Developments and Future Plans

2.16 ClinicalTrials.gov

2.16.1 ClinicalTrials.gov Details

2.16.2 ClinicalTrials.gov Major Business

2.16.3 ClinicalTrials.gov Pharmaceutical Blockchain Product and Solutions

2.16.4 ClinicalTrials.gov Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.16.5 ClinicalTrials.gov Recent Developments and Future Plans

2.17 Medpace

2.17.1 Medpace Details

2.17.2 Medpace Major Business

2.17.3 Medpace Pharmaceutical Blockchain Product and Solutions

2.17.4 Medpace Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.17.5 Medpace Recent Developments and Future Plans

2.18 N-SIDE

2.18.1 N-SIDE Details

2.18.2 N-SIDE Major Business

2.18.3 N-SIDE Pharmaceutical Blockchain Product and Solutions

2.18.4 N-SIDE Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.18.5 N-SIDE Recent Developments and Future Plans

2.19 Quanticate

2.19.1 Quanticate Details

2.19.2 Quanticate Major Business

2.19.3 Quanticate Pharmaceutical Blockchain Product and Solutions

2.19.4 Quanticate Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.19.5 Quanticate Recent Developments and Future Plans

2.20 Society for Clinical Trials

2.20.1 Society for Clinical Trials Details

2.20.2 Society for Clinical Trials Major Business

2.20.3 Society for Clinical Trials Pharmaceutical Blockchain Product and Solutions

2.20.4 Society for Clinical Trials Pharmaceutical Blockchain Revenue, Gross Margin and Market Share (2018-2023)

2.20.5 Society for Clinical Trials Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Pharmaceutical Blockchain Revenue and Share by Players (2018-2023)

3.2 Market Share Analysis (2022)

3.2.1 Market Share of Pharmaceutical Blockchain by Company Revenue

3.2.2 Top 3 Pharmaceutical Blockchain Players Market Share in 2022

3.2.3 Top 6 Pharmaceutical Blockchain Players Market Share in 2022

3.3 Pharmaceutical Blockchain Market: Overall Company Footprint Analysis

3.3.1 Pharmaceutical Blockchain Market: Region Footprint

3.3.2 Pharmaceutical Blockchain Market: Company Product Type Footprint

3.3.3 Pharmaceutical Blockchain Market: Company Product Application Footprint

3.4 New Market Entrants and Barriers to Market Entry

3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Pharmaceutical Blockchain Consumption Value and Market Share by Type (2018-2023)

4.2 Global Pharmaceutical Blockchain Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

5.1 Global Pharmaceutical Blockchain Consumption Value Market Share by Application (2018-2023)

5.2 Global Pharmaceutical Blockchain Market Forecast by Application (2024-2029)

6 North America

6.1 North America Pharmaceutical Blockchain Consumption Value by Type (2018-2029)

6.2 North America Pharmaceutical Blockchain Consumption Value by Application (2018-2029)

6.3 North America Pharmaceutical Blockchain Market Size by Country

6.3.1 North America Pharmaceutical Blockchain Consumption Value by Country (2018-2029)

6.3.2 United States Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

6.3.3 Canada Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

6.3.4 Mexico Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

7 Europe

7.1 Europe Pharmaceutical Blockchain Consumption Value by Type (2018-2029)

7.2 Europe Pharmaceutical Blockchain Consumption Value by Application (2018-2029)

7.3 Europe Pharmaceutical Blockchain Market Size by Country

7.3.1 Europe Pharmaceutical Blockchain Consumption Value by Country (2018-2029)

7.3.2 Germany Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

7.3.3 France Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

7.3.4 United Kingdom Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

7.3.5 Russia Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

7.3.6 Italy Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

8 Asia-Pacific

8.1 Asia-Pacific Pharmaceutical Blockchain Consumption Value by Type (2018-2029)

8.2 Asia-Pacific Pharmaceutical Blockchain Consumption Value by Application (2018-2029)

8.3 Asia-Pacific Pharmaceutical Blockchain Market Size by Region

8.3.1 Asia-Pacific Pharmaceutical Blockchain Consumption Value by Region (2018-2029)

8.3.2 China Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

8.3.3 Japan Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

8.3.4 South Korea Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

8.3.5 India Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

8.3.6 Southeast Asia Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

8.3.7 Australia Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

9 South America

9.1 South America Pharmaceutical Blockchain Consumption Value by Type (2018-2029)

9.2 South America Pharmaceutical Blockchain Consumption Value by Application (2018-2029)

9.3 South America Pharmaceutical Blockchain Market Size by Country

9.3.1 South America Pharmaceutical Blockchain Consumption Value by Country (2018-2029)

9.3.2 Brazil Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

9.3.3 Argentina Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

10 Middle East & Africa

10.1 Middle East & Africa Pharmaceutical Blockchain Consumption Value by Type (2018-2029)

10.2 Middle East & Africa Pharmaceutical Blockchain Consumption Value by Application (2018-2029)

10.3 Middle East & Africa Pharmaceutical Blockchain Market Size by Country

10.3.1 Middle East & Africa Pharmaceutical Blockchain Consumption Value by Country (2018-2029)

10.3.2 Turkey Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

10.3.3 Saudi Arabia Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

10.3.4 UAE Pharmaceutical Blockchain Market Size and Forecast (2018-2029)

11 Market Dynamics

11.1 Pharmaceutical Blockchain Market Drivers

11.2 Pharmaceutical Blockchain Market Restraints

11.3 Pharmaceutical Blockchain Trends Analysis

11.4 Porters Five Forces Analysis

11.4.1 Threat of New Entrants

11.4.2 Bargaining Power of Suppliers

11.4.3 Bargaining Power of Buyers

11.4.4 Threat of Substitutes

11.4.5 Competitive Rivalry

11.5 Influence of COVID-19 and Russia-Ukraine War

11.5.1 Influence of COVID-19

11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

12.1 Pharmaceutical Blockchain Industry Chain

12.2 Pharmaceutical Blockchain Upstream Analysis

12.3 Pharmaceutical Blockchain Midstream Analysis

12.4 Pharmaceutical Blockchain Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Pharmaceutical Blockchain Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Pharmaceutical Blockchain Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. Global Pharmaceutical Blockchain Consumption Value by Region (2018-2023) & (USD Million)

Table 4. Global Pharmaceutical Blockchain Consumption Value by Region (2024-2029) & (USD Million)

Table 5. Chronicled Inc. Company Information, Head Office, and Major Competitors

Table 6. Chronicled Inc. Major Business

Table 7. Chronicled Inc. Pharmaceutical Blockchain Product and Solutions

Table 8. Chronicled Inc. Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 9. Chronicled Inc. Recent Developments and Future Plans

Table 10. Doc.AI Company Information, Head Office, and Major Competitors

Table 11. Doc.AI Major Business

Table 12. Doc.AI Pharmaceutical Blockchain Product and Solutions

Table 13. Doc.AI Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 14. Doc.AI Recent Developments and Future Plans

Table 15. Embleema Company Information, Head Office, and Major Competitors

Table 16. Embleema Major Business

Table 17. Embleema Pharmaceutical Blockchain Product and Solutions

Table 18. Embleema Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 19. Embleema Recent Developments and Future Plans

Table 20. Factom Inc. Company Information, Head Office, and Major Competitors

Table 21. Factom Inc. Major Business

Table 22. Factom Inc. Pharmaceutical Blockchain Product and Solutions

Table 23. Factom Inc. Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 24. Factom Inc. Recent Developments and Future Plans

Table 25. FarmaTrust Company Information, Head Office, and Major Competitors

Table 26. FarmaTrust Major Business

Table 27. FarmaTrust Pharmaceutical Blockchain Product and Solutions

Table 28. FarmaTrust Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 29. FarmaTrust Recent Developments and Future Plans

Table 30. Guardtime Federal Company Information, Head Office, and Major Competitors

Table 31. Guardtime Federal Major Business

Table 32. Guardtime Federal Pharmaceutical Blockchain Product and Solutions

Table 33. Guardtime Federal Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 34. Guardtime Federal Recent Developments and Future Plans

Table 35. Hashed Health Company Information, Head Office, and Major Competitors

Table 36. Hashed Health Major Business

Table 37. Hashed Health Pharmaceutical Blockchain Product and Solutions

Table 38. Hashed Health Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 39. Hashed Health Recent Developments and Future Plans

Table 40. IBM Corporation Company Information, Head Office, and Major Competitors

Table 41. IBM Corporation Major Business

Table 42. IBM Corporation Pharmaceutical Blockchain Product and Solutions

Table 43. IBM Corporation Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 44. IBM Corporation Recent Developments and Future Plans

Table 45. Medicalchain Company Information, Head Office, and Major Competitors

Table 46. Medicalchain Major Business

Table 47. Medicalchain Pharmaceutical Blockchain Product and Solutions

Table 48. Medicalchain Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 49. Medicalchain Recent Developments and Future Plans

Table 50. Microsoft Corporation Company Information, Head Office, and Major Competitors

Table 51. Microsoft Corporation Major Business

Table 52. Microsoft Corporation Pharmaceutical Blockchain Product and Solutions

Table 53. Microsoft Corporation Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 54. Microsoft Corporation Recent Developments and Future Plans

Table 55. Organizations Mentioned Company Information, Head Office, and Major Competitors

Table 56. Organizations Mentioned Major Business

Table 57. Organizations Mentioned Pharmaceutical Blockchain Product and Solutions

Table 58. Organizations Mentioned Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 59. Organizations Mentioned Recent Developments and Future Plans

Table 60. American Society of Clinical Oncology (ASCO) Company Information, Head Office, and Major Competitors

Table 61. American Society of Clinical Oncology (ASCO) Major Business

Table 62. American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Product and Solutions

Table 63. American Society of Clinical Oncology (ASCO) Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 64. American Society of Clinical Oncology (ASCO) Recent Developments and Future Plans

Table 65. Association of Clinical Trials Organizations (ACTO) Company Information, Head Office, and Major Competitors

Table 66. Association of Clinical Trials Organizations (ACTO) Major Business

Table 67. Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Product and Solutions

Table 68. Association of Clinical Trials Organizations (ACTO) Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 69. Association of Clinical Trials Organizations (ACTO) Recent Developments and Future Plans

Table 70. Castor EDC Company Information, Head Office, and Major Competitors

Table 71. Castor EDC Major Business

Table 72. Castor EDC Pharmaceutical Blockchain Product and Solutions

Table 73. Castor EDC Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 74. Castor EDC Recent Developments and Future Plans

Table 75. Clinical Supplies Management Holdings, Inc. Company Information, Head Office, and Major Competitors

Table 76. Clinical Supplies Management Holdings, Inc. Major Business

Table 77. Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Product and Solutions

Table 78. Clinical Supplies Management Holdings, Inc. Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 79. Clinical Supplies Management Holdings, Inc. Recent Developments and Future Plans

Table 80. ClinicalTrials.gov Company Information, Head Office, and Major Competitors

Table 81. ClinicalTrials.gov Major Business

Table 82. ClinicalTrials.gov Pharmaceutical Blockchain Product and Solutions

Table 83. ClinicalTrials.gov Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 84. ClinicalTrials.gov Recent Developments and Future Plans

Table 85. Medpace Company Information, Head Office, and Major Competitors

Table 86. Medpace Major Business

Table 87. Medpace Pharmaceutical Blockchain Product and Solutions

Table 88. Medpace Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 89. Medpace Recent Developments and Future Plans

Table 90. N-SIDE Company Information, Head Office, and Major Competitors

Table 91. N-SIDE Major Business

Table 92. N-SIDE Pharmaceutical Blockchain Product and Solutions

Table 93. N-SIDE Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 94. N-SIDE Recent Developments and Future Plans

Table 95. Quanticate Company Information, Head Office, and Major Competitors

Table 96. Quanticate Major Business

Table 97. Quanticate Pharmaceutical Blockchain Product and Solutions

Table 98. Quanticate Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 99. Quanticate Recent Developments and Future Plans

Table 100. Society for Clinical Trials Company Information, Head Office, and Major Competitors

Table 101. Society for Clinical Trials Major Business

Table 102. Society for Clinical Trials Pharmaceutical Blockchain Product and Solutions

Table 103. Society for Clinical Trials Pharmaceutical Blockchain Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 104. Society for Clinical Trials Recent Developments and Future Plans

Table 105. Global Pharmaceutical Blockchain Revenue (USD Million) by Players (2018-2023)

Table 106. Global Pharmaceutical Blockchain Revenue Share by Players (2018-2023)

Table 107. Breakdown of Pharmaceutical Blockchain by Company Type (Tier 1, Tier 2, and Tier 3)

Table 108. Market Position of Players in Pharmaceutical Blockchain, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022

Table 109. Head Office of Key Pharmaceutical Blockchain Players

Table 110. Pharmaceutical Blockchain Market: Company Product Type Footprint

Table 111. Pharmaceutical Blockchain Market: Company Product Application Footprint

Table 112. Pharmaceutical Blockchain New Market Entrants and Barriers to Market Entry

Table 113. Pharmaceutical Blockchain Mergers, Acquisition, Agreements, and Collaborations

Table 114. Global Pharmaceutical Blockchain Consumption Value (USD Million) by Type (2018-2023)

Table 115. Global Pharmaceutical Blockchain Consumption Value Share by Type (2018-2023)

Table 116. Global Pharmaceutical Blockchain Consumption Value Forecast by Type (2024-2029)

Table 117. Global Pharmaceutical Blockchain Consumption Value by Application (2018-2023)

Table 118. Global Pharmaceutical Blockchain Consumption Value Forecast by Application (2024-2029)

Table 119. North America Pharmaceutical Blockchain Consumption Value by Type (2018-2023) & (USD Million)

Table 120. North America Pharmaceutical Blockchain Consumption Value by Type (2024-2029) & (USD Million)

Table 121. North America Pharmaceutical Blockchain Consumption Value by Application (2018-2023) & (USD Million)

Table 122. North America Pharmaceutical Blockchain Consumption Value by Application (2024-2029) & (USD Million)

Table 123. North America Pharmaceutical Blockchain Consumption Value by Country (2018-2023) & (USD Million)

Table 124. North America Pharmaceutical Blockchain Consumption Value by Country (2024-2029) & (USD Million)

Table 125. Europe Pharmaceutical Blockchain Consumption Value by Type (2018-2023) & (USD Million)

Table 126. Europe Pharmaceutical Blockchain Consumption Value by Type (2024-2029) & (USD Million)

Table 127. Europe Pharmaceutical Blockchain Consumption Value by Application (2018-2023) & (USD Million)

Table 128. Europe Pharmaceutical Blockchain Consumption Value by Application (2024-2029) & (USD Million)

Table 129. Europe Pharmaceutical Blockchain Consumption Value by Country (2018-2023) & (USD Million)

Table 130. Europe Pharmaceutical Blockchain Consumption Value by Country (2024-2029) & (USD Million)

Table 131. Asia-Pacific Pharmaceutical Blockchain Consumption Value by Type (2018-2023) & (USD Million)

Table 132. Asia-Pacific Pharmaceutical Blockchain Consumption Value by Type (2024-2029) & (USD Million)

Table 133. Asia-Pacific Pharmaceutical Blockchain Consumption Value by Application (2018-2023) & (USD Million)

Table 134. Asia-Pacific Pharmaceutical Blockchain Consumption Value by Application (2024-2029) & (USD Million)

Table 135. Asia-Pacific Pharmaceutical Blockchain Consumption Value by Region (2018-2023) & (USD Million)

Table 136. Asia-Pacific Pharmaceutical Blockchain Consumption Value by Region (2024-2029) & (USD Million)

Table 137. South America Pharmaceutical Blockchain Consumption Value by Type (2018-2023) & (USD Million)

Table 138. South America Pharmaceutical Blockchain Consumption Value by Type (2024-2029) & (USD Million)

Table 139. South America Pharmaceutical Blockchain Consumption Value by Application (2018-2023) & (USD Million)

Table 140. South America Pharmaceutical Blockchain Consumption Value by Application (2024-2029) & (USD Million)

Table 141. South America Pharmaceutical Blockchain Consumption Value by Country (2018-2023) & (USD Million)

Table 142. South America Pharmaceutical Blockchain Consumption Value by Country (2024-2029) & (USD Million)

Table 143. Middle East & Africa Pharmaceutical Blockchain Consumption Value by Type (2018-2023) & (USD Million)

Table 144. Middle East & Africa Pharmaceutical Blockchain Consumption Value by Type (2024-2029) & (USD Million)

Table 145. Middle East & Africa Pharmaceutical Blockchain Consumption Value by Application (2018-2023) & (USD Million)

Table 146. Middle East & Africa Pharmaceutical Blockchain Consumption Value by Application (2024-2029) & (USD Million)

Table 147. Middle East & Africa Pharmaceutical Blockchain Consumption Value by Country (2018-2023) & (USD Million)

Table 148. Middle East & Africa Pharmaceutical Blockchain Consumption Value by Country (2024-2029) & (USD Million)

Table 149. Pharmaceutical Blockchain Raw Material

Table 150. Key Suppliers of Pharmaceutical Blockchain Raw Materials

List of Figures

Figure 1. Pharmaceutical Blockchain Picture

Figure 2. Global Pharmaceutical Blockchain Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Pharmaceutical Blockchain Consumption Value Market Share by Type in 2022

Figure 4. Public

Figure 5. Private

Figure 6. Global Pharmaceutical Blockchain Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 7. Pharmaceutical Blockchain Consumption Value Market Share by Application in 2022

Figure 8. Supply Chian Management Picture

Figure 9. Clinical Data Exchange and Interoperability Picture

Figure 10. Drug Development Picture

Figure 11. Clinical Trials Picture

Figure 12. Internet of Medical Things (IOMT)& Cyber Security Picture

Figure 13. Other Applications Picture

Figure 14. Global Pharmaceutical Blockchain Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 15. Global Pharmaceutical Blockchain Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 16. Global Market Pharmaceutical Blockchain Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)

Figure 17. Global Pharmaceutical Blockchain Consumption Value Market Share by Region (2018-2029)

Figure 18. Global Pharmaceutical Blockchain Consumption Value Market Share by Region in 2022

Figure 19. North America Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 20. Europe Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 21. Asia-Pacific Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 22. South America Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 23. Middle East and Africa Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 24. Global Pharmaceutical Blockchain Revenue Share by Players in 2022

Figure 25. Pharmaceutical Blockchain Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022

Figure 26. Global Top 3 Players Pharmaceutical Blockchain Market Share in 2022

Figure 27. Global Top 6 Players Pharmaceutical Blockchain Market Share in 2022

Figure 28. Global Pharmaceutical Blockchain Consumption Value Share by Type (2018-2023)

Figure 29. Global Pharmaceutical Blockchain Market Share Forecast by Type (2024-2029)

Figure 30. Global Pharmaceutical Blockchain Consumption Value Share by Application (2018-2023)

Figure 31. Global Pharmaceutical Blockchain Market Share Forecast by Application (2024-2029)

Figure 32. North America Pharmaceutical Blockchain Consumption Value Market Share by Type (2018-2029)

Figure 33. North America Pharmaceutical Blockchain Consumption Value Market Share by Application (2018-2029)

Figure 34. North America Pharmaceutical Blockchain Consumption Value Market Share by Country (2018-2029)

Figure 35. United States Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 36. Canada Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 37. Mexico Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 38. Europe Pharmaceutical Blockchain Consumption Value Market Share by Type (2018-2029)

Figure 39. Europe Pharmaceutical Blockchain Consumption Value Market Share by Application (2018-2029)

Figure 40. Europe Pharmaceutical Blockchain Consumption Value Market Share by Country (2018-2029)

Figure 41. Germany Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 42. France Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 43. United Kingdom Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 44. Russia Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 45. Italy Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 46. Asia-Pacific Pharmaceutical Blockchain Consumption Value Market Share by Type (2018-2029)

Figure 47. Asia-Pacific Pharmaceutical Blockchain Consumption Value Market Share by Application (2018-2029)

Figure 48. Asia-Pacific Pharmaceutical Blockchain Consumption Value Market Share by Region (2018-2029)

Figure 49. China Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 50. Japan Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 51. South Korea Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 52. India Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 53. Southeast Asia Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 54. Australia Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 55. South America Pharmaceutical Blockchain Consumption Value Market Share by Type (2018-2029)

Figure 56. South America Pharmaceutical Blockchain Consumption Value Market Share by Application (2018-2029)

Figure 57. South America Pharmaceutical Blockchain Consumption Value Market Share by Country (2018-2029)

Figure 58. Brazil Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 59. Argentina Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 60. Middle East and Africa Pharmaceutical Blockchain Consumption Value Market Share by Type (2018-2029)

Figure 61. Middle East and Africa Pharmaceutical Blockchain Consumption Value Market Share by Application (2018-2029)

Figure 62. Middle East and Africa Pharmaceutical Blockchain Consumption Value Market Share by Country (2018-2029)

Figure 63. Turkey Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 64. Saudi Arabia Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 65. UAE Pharmaceutical Blockchain Consumption Value (2018-2029) & (USD Million)

Figure 66. Pharmaceutical Blockchain Market Drivers

Figure 67. Pharmaceutical Blockchain Market Restraints

Figure 68. Pharmaceutical Blockchain Market Trends

Figure 69. Porters Five Forces Analysis

Figure 70. Manufacturing Cost Structure Analysis of Pharmaceutical Blockchain in 2022

Figure 71. Manufacturing Process Analysis of Pharmaceutical Blockchain

Figure 72. Pharmaceutical Blockchain Industrial Chain

Figure 73. Methodology

Figure 74. Research Process and Data Source